Cargando…
Biological effects of COVID-19 on lung cancer: Can we drive our decisions
COVID-19 infection caused by SARS-CoV-2 is considered catastrophic because it affects multiple organs, particularly those of the respiratory tract. Although the consequences of this infection are not fully clear, it causes damage to the lungs, the cardiovascular and nervous systems, and other organs...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589049/ https://www.ncbi.nlm.nih.gov/pubmed/36300087 http://dx.doi.org/10.3389/fonc.2022.1029830 |
_version_ | 1784814212882628608 |
---|---|
author | Aramini, Beatrice Masciale, Valentina Samarelli, Anna Valeria Tonelli, Roberto Cerri, Stefania Clini, Enrico Stella, Franco Dominici, Massimo |
author_facet | Aramini, Beatrice Masciale, Valentina Samarelli, Anna Valeria Tonelli, Roberto Cerri, Stefania Clini, Enrico Stella, Franco Dominici, Massimo |
author_sort | Aramini, Beatrice |
collection | PubMed |
description | COVID-19 infection caused by SARS-CoV-2 is considered catastrophic because it affects multiple organs, particularly those of the respiratory tract. Although the consequences of this infection are not fully clear, it causes damage to the lungs, the cardiovascular and nervous systems, and other organs, subsequently inducing organ failure. In particular, the effects of SARS-CoV-2-induced inflammation on cancer cells and the tumor microenvironment need to be investigated. COVID-19 may alter the tumor microenvironment, promoting cancer cell proliferation and dormant cancer cell (DCC) reawakening. DCCs reawakened upon infection with SARS-CoV-2 can populate the premetastatic niche in the lungs and other organs, leading to tumor dissemination. DCC reawakening and consequent neutrophil and monocyte/macrophage activation with an uncontrolled cascade of pro-inflammatory cytokines are the most severe clinical effects of COVID-19. Moreover, neutrophil extracellular traps have been demonstrated to activate the dissemination of premetastatic cells into the lungs. Further studies are warranted to better define the roles of COVID-19 in inflammation as well as in tumor development and tumor cell metastasis; the results of these studies will aid in the development of further targeted therapies, both for cancer prevention and the treatment of patients with COVID-19. |
format | Online Article Text |
id | pubmed-9589049 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95890492022-10-25 Biological effects of COVID-19 on lung cancer: Can we drive our decisions Aramini, Beatrice Masciale, Valentina Samarelli, Anna Valeria Tonelli, Roberto Cerri, Stefania Clini, Enrico Stella, Franco Dominici, Massimo Front Oncol Oncology COVID-19 infection caused by SARS-CoV-2 is considered catastrophic because it affects multiple organs, particularly those of the respiratory tract. Although the consequences of this infection are not fully clear, it causes damage to the lungs, the cardiovascular and nervous systems, and other organs, subsequently inducing organ failure. In particular, the effects of SARS-CoV-2-induced inflammation on cancer cells and the tumor microenvironment need to be investigated. COVID-19 may alter the tumor microenvironment, promoting cancer cell proliferation and dormant cancer cell (DCC) reawakening. DCCs reawakened upon infection with SARS-CoV-2 can populate the premetastatic niche in the lungs and other organs, leading to tumor dissemination. DCC reawakening and consequent neutrophil and monocyte/macrophage activation with an uncontrolled cascade of pro-inflammatory cytokines are the most severe clinical effects of COVID-19. Moreover, neutrophil extracellular traps have been demonstrated to activate the dissemination of premetastatic cells into the lungs. Further studies are warranted to better define the roles of COVID-19 in inflammation as well as in tumor development and tumor cell metastasis; the results of these studies will aid in the development of further targeted therapies, both for cancer prevention and the treatment of patients with COVID-19. Frontiers Media S.A. 2022-10-10 /pmc/articles/PMC9589049/ /pubmed/36300087 http://dx.doi.org/10.3389/fonc.2022.1029830 Text en Copyright © 2022 Aramini, Masciale, Samarelli, Tonelli, Cerri, Clini, Stella and Dominici https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Aramini, Beatrice Masciale, Valentina Samarelli, Anna Valeria Tonelli, Roberto Cerri, Stefania Clini, Enrico Stella, Franco Dominici, Massimo Biological effects of COVID-19 on lung cancer: Can we drive our decisions |
title | Biological effects of COVID-19 on lung cancer: Can we drive our decisions |
title_full | Biological effects of COVID-19 on lung cancer: Can we drive our decisions |
title_fullStr | Biological effects of COVID-19 on lung cancer: Can we drive our decisions |
title_full_unstemmed | Biological effects of COVID-19 on lung cancer: Can we drive our decisions |
title_short | Biological effects of COVID-19 on lung cancer: Can we drive our decisions |
title_sort | biological effects of covid-19 on lung cancer: can we drive our decisions |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589049/ https://www.ncbi.nlm.nih.gov/pubmed/36300087 http://dx.doi.org/10.3389/fonc.2022.1029830 |
work_keys_str_mv | AT araminibeatrice biologicaleffectsofcovid19onlungcancercanwedriveourdecisions AT mascialevalentina biologicaleffectsofcovid19onlungcancercanwedriveourdecisions AT samarelliannavaleria biologicaleffectsofcovid19onlungcancercanwedriveourdecisions AT tonelliroberto biologicaleffectsofcovid19onlungcancercanwedriveourdecisions AT cerristefania biologicaleffectsofcovid19onlungcancercanwedriveourdecisions AT clinienrico biologicaleffectsofcovid19onlungcancercanwedriveourdecisions AT stellafranco biologicaleffectsofcovid19onlungcancercanwedriveourdecisions AT dominicimassimo biologicaleffectsofcovid19onlungcancercanwedriveourdecisions |